TLX591-CDx (Illuccix® in approved jurisdictions, 68 Ga-PSMA-11 ): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China.
Telix Pharmaceuticals reports strong Illuccix China results and FDA progress on TLX101-CDx and TLX250-CDx. Read the latest ...
Disney+ and Hulu will soon be merging into a single streaming service, with one login working for both (but you can watch ...
"I volunteered, as I was bored out of my mind anyway. I arrive at the house, and the entry gate is smashed, a section of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback